Results 71 to 80 of about 105,578,950 (193)

The concentrations of plasma a-2-AP and PAI-1 in the patients with OSA and the control group.

open access: yes, 2016
The concentrations of alpha-2-antiplasmin and PAI-1 in peripheral blood plasma were determined by enzyme-linked immunosorbent assay (ELISA) in 45 OSA patients and 19 controls. (A) and (B) The concentrations of plasma a-2-AP and PAI-1 in the patients with
Jolanta Pastryk (3353465)   +8 more
core   +1 more source

Clotting alterations in primary systemic amyloidosis

open access: yesHaematologica, 2000
BACKGROUND AND OBJECTIVE: The bleeding manifestations frequently observed in patients with immunoglobulin light chain amyloidosis (AL) have been attributed to different pathogenetic factors: amyloid deposits in several organs and systems leading to ...
G Gamba   +6 more
doaj  

Alpha Kappa Alpha EAF Awards luncheon program, July 15, 2014

open access: yes, 2014
This program for the Educational Advancement Foundation (EAF) Awards luncheon given by the Alpha Kappa Alpha sorority notes the sequence of events, leaders of the EAF, and sponsors for the gathering.Archival master image scanned in reflective mode as 48 ...
Alpha Kappa Alpha
core   +1 more source

Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme

open access: yes, 1960
When streptokinase-activated, urokinase-activated, or spontaneously activated human plasmin is mixed with increasing amounts of human antiplasmin, caseinolytic effect decreases much more rapidly than fibrinolytic effect. At concentrations of antiplasmin
Clara M. Ambrus, Gabor Markus
core   +1 more source

The plasmin-antiplasmin system: structural and functional aspects [PDF]

open access: yes, 2018
The plasmin-antiplasmin system plays a key role in blood coagulation and fibrinolysis. Plasmin and α2-antiplasmin are primarily responsible for a controlled and regulated dissolution of the fibrin polymers into soluble fragments. However, besides plasmin(
Gerber, Simon, Schaller, Johann
core  

Targeted exome analysis in patients with rare bleeding disorders: data from the Rare Bleeding Disorders in the Netherlands study

open access: yesResearch and Practice in Thrombosis and Haemostasis
Background: Rare coagulation factor deficiencies and disorders of fibrinolysis (defined as rare bleeding disorders [RBDs]) present with a heterogeneous bleeding phenotype, and bleeding severity is difficult to predict.
Sterre P.E. Willems   +15 more
doaj   +1 more source

Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: Specific role of the plasminogen-binding form of α2-antiplasmin

open access: yes, 1990
To delineate the role of plasmin inhibitors, especially the two molecular forms of α2-antiplasmin (that is, the plasminogen-binding and the nonplasminogen-binding forms), in the control of systemic effects during thrombolytic therapy, the consumption of ...
Knot, E.A.R.   +5 more
core  

Proteolytic and genetic variation of the alpha-2-antiplasmin C-terminus in myocardial infarction

open access: yes, 2011
Alpha-2-antiplasmin (alpha 2AP) undergoes both N- and C-terminal cleavages, which significantly modify its activities. Compared with other Ser protease inhibitors (serpins), alpha 2AP contains an similar to 50-residue-extended C-terminus, which binds ...
Lisman, T.   +23 more
core   +1 more source

Haemostatic Parameters in Patients with Behçet’s Disease

open access: yesSultan Qaboos University Medical Journal, 2014
Objectives: This study aimed to evaluate the cause of thrombosis in Behçet’s disease (BD) patients, since abnormalities in coagulation and fibrinolytic parameters have shown contradictory results.
Juma K. Alkaabi   +3 more
doaj   +2 more sources

Carbon Monoxide and Nitric Oxide Induced-Heme-Based Modification of Alpha-2-Antiplasmin and Plasmin Activity [PDF]

open access: yes, 2011
Objectives: Carbon monoxide (CO) derived from cigarette smoke or released from carbon monoxide releasing-molecule 2 (CORM-2), diminishes fibrinolysis. The primary purpose of this study was to determine if CO diminished fibrinolysis by means of enhancing ...
Arkebauer, Matthew R.
core  

Home - About - Disclaimer - Privacy